OLD Mission Capital LLC increased its position in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 35.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 134,884 shares of the technology company's stock after buying an additional 35,087 shares during the period. OLD Mission Capital LLC's holdings in Koninklijke Philips were worth $3,426,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. QRG Capital Management Inc. increased its position in shares of Koninklijke Philips by 11.0% in the 1st quarter. QRG Capital Management Inc. now owns 142,595 shares of the technology company's stock worth $3,622,000 after purchasing an additional 14,090 shares during the last quarter. Aurora Private Wealth Inc. bought a new stake in shares of Koninklijke Philips in the 1st quarter worth about $1,695,000. Quantinno Capital Management LP increased its position in shares of Koninklijke Philips by 71.1% in the 4th quarter. Quantinno Capital Management LP now owns 180,149 shares of the technology company's stock worth $4,561,000 after purchasing an additional 74,835 shares during the last quarter. Cerity Partners LLC increased its position in shares of Koninklijke Philips by 30.6% in the 1st quarter. Cerity Partners LLC now owns 80,767 shares of the technology company's stock worth $2,051,000 after purchasing an additional 18,906 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Koninklijke Philips by 2.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,396,095 shares of the technology company's stock worth $111,662,000 after purchasing an additional 106,044 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen downgraded shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy".
Get Our Latest Research Report on Koninklijke Philips
Koninklijke Philips Stock Performance
Koninklijke Philips stock traded down $0.54 during midday trading on Tuesday, reaching $27.05. 590,550 shares of the stock traded hands, compared to its average volume of 981,492. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69. The firm has a fifty day moving average price of $25.86 and a two-hundred day moving average price of $24.98. The firm has a market cap of $26.04 billion, a price-to-earnings ratio of 142.34, a PEG ratio of 0.75 and a beta of 0.81. Koninklijke Philips N.V. has a fifty-two week low of $21.48 and a fifty-two week high of $32.91.
Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The technology company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.12. The firm had revenue of $5.05 billion during the quarter, compared to analyst estimates of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. On average, equities research analysts forecast that Koninklijke Philips N.V. will post 1.63 earnings per share for the current year.
Koninklijke Philips Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Stories

Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.